Harvest Fund Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55K Hold
364
﹤0.01% 337
2026
Q1
$34K Sell
364
-1,500
-80% -$151K ﹤0.01% 370
2025
Q4
$190K Hold
1,864
0.01% 349
2025
Q3
$117K Buy
+1,864
New +$101K 0.01% 376
2024
Q3
Sell
-3,331
Closed -$96K 658
2024
Q2
$96K Buy
+3,331
New +$77.6K 0.01% 415
2023
Q4
Sell
-140
Closed -$4K 660
2023
Q3
$4K Sell
140
-102
-42% -$3.59K ﹤0.01% 577
2023
Q2
$9K Buy
+242
New +$6.95K ﹤0.01% 563
2021
Q2
Sell
-98
Closed -$14K 798
2021
Q1
$14K Buy
+98
New +$14.8K ﹤0.01% 702
2020
Q1
Sell
-651
Closed -$52K 435
2019
Q4
$52K Buy
+651
New +$46.9K 0.01% 282

Other funds holding GH

Harvest Fund Management's GH Position: Q2 2026 in Review

Harvest Fund Management held its Guardant Health (GH) position steady in Q2 2026 at 364 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Harvest Fund Management first reported a position in GH in Q4 2019 and has held it in 9 quarters since. The position peaked at $190K in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Harvest Fund Management held 364 shares of Guardant Health worth $55K as of Q2 2026.
  • Harvest Fund Management left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Harvest Fund Management's portfolio in Q2 2026, its #337 holding.
  • Harvest Fund Management first reported a position in Guardant Health in Q4 2019 and has held it in 9 quarters since.
  • Harvest Fund Management's Guardant Health position peaked at $190K in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.